iRhythm Holdings, Inc. (IRTC): Total Liabilities
$867.30M
As of 2025-12-31
$907.44M
As of 2026-06-30
+60.8%
3-year compound annual growth
+38.5%
5-year compound annual growth
+35.2%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $867.30M | +3.2% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $840.54M | +276.8% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $223.05M | +7.0% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $208.41M | +13.6% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $183.45M | +7.8% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $170.13M | -0.4% | 2022-02-28, Balance as of period end |
| 2019-12-31 | $170.80M | +161.2% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $65.39M | +22.1% | 2021-02-26, Balance as of period end |
| 2017-12-31 | $53.57M | +17.5% | 2019-03-04, Balance as of period end |
| 2016-12-31 | $45.59M | +7.5% | 2018-03-01, Balance as of period end |
| 2015-12-31 | $42.40M | n/a | 2017-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $867.30M | +3.2% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $400.61M | +2.7% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $463.86M | -47.3% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $126.16M | +6.3% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $231.20M | -19.2% |
| Bioventus Inc. (BVS) | 2025-12-31 | $455.11M | -16.1% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $725.94M | +3.0% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $162.24M | +9.4% |
| Glaukos Corp (GKOS) | 2025-12-31 | $237.33M | +14.2% |
Compare IRTC, OFIX, NVCR, INSP side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗